FDA's Drug Center Permits Some Combo Product Software To Be Submitted As DMFs
Executive Summary
New draft guidance from the US agency allows electronics or software that will be used across multiple combination products to be submitted as a Type V drug master file (DMF), potentially streamlining the assessment process.